Diazoxide
규격
364-98-7CAS 번호
206-668-1EC 번호
7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxideIUPAC 명칭
C8H7ClN2O2S화학식
230.67 g/mol분자량
diazoxide; 364-98-7; Proglycem; Hyperstat; Hypertonalum; Mutabase; 7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide; Diazossido; Diazoxido; Diazoxidum; Sch 6783; Sch-6783; SRG 95213; SRG-95213; Eudemine injection; 2H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide; NSC-64198; DTXSID7022914; 3-methyl-7-chloro-1,2,4-benzothiadiazine 1,1-dioxide; CHEBI:4495; Eudimine; O5CB12L4FN; NSC-76130; NSC64198; NSC76130; DTXCID902914; 7-chloro-3-methyl-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide; 7-chloro-3-methyl-4H-benzo(e)(1,2,4)thiadiazine 1,1-dioxide; 7-chloro-3-methyl-4H-1$l^(6),2,4-benzothiadiazine-1,1-dione; 7-chloro-3-methyl-4H-1$l^{6},2,4-benzothiadiazine-1,1-dione; RefChem:54996; C02DA01; V03AH01; 206-668-1; Eudemine; Proglicem; Dizoxide; MFCD00078578; NSC 76130; MLS000028459; 7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine1,1-dioxide; 7-Cloro-3-metil-2H-1,2,4-benzotiodiazina-1,1-diossido; Diazossido [Italian]; 7-chloro-3-methyl-4h-1,2,4-benzothiadiazine 1,1-dioxide; Diazossido [DCIT]; NCGC00015380-09; CAS-364-98-7; SMR000058392; 7-Chloro-3-methyl-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide; 7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide; Diazoxidum [INN-Latin]; Diazoxido [INN-Spanish]; Aroglycem; Hyperstat (TN); SR-01000075314; EINECS 206-668-1; NSC 64198; UNII-O5CB12L4FN; 7-Chloro-3-methyl-2H-1,4-benzothiadiazine 1,1-dioxide; Diazoxide (JAN/USP/INN); 2H-1,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide; Diazoxide CRS; 364-98-7 (free); 7-chloro-3-methyl-4H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide; 7-Cloro-3-metil-2H-1,2,4-benzotiodiazina-1,1-diossido [Italian]; Proglycem (TN); Prestwick_163; Diazoxide (Standard); Diazoxide [USAN:USP:INN:BAN:JAN]; Tocris-0964; DIAZOXIDE [INN]; DIAZOXIDE [JAN]; Opera_ID_608; DIAZOXIDE [MI]; DIAZOXIDE [USAN]; Prestwick0_000087; Prestwick1_000087; Prestwick2_000087; Prestwick3_000087; Spectrum3_000735; Spectrum4_001248; DIAZOXIDE [VANDF]; Lopac-D-9035; CHEMBL181; DIAZOXIDE [MART.]; Epitope ID:768764; D 9035; DIAZOXIDE [USP-RS]; DIAZOXIDE [WHO-DD]; DIAZOXIDE [WHO-IP]; CBiol_001750; Lopac0_000404; SCHEMBL41254; SCHEMBL41255; BSPBio_000014; BSPBio_001307; BSPBio_002290; KBioGR_000027; KBioGR_001776; KBioSS_000027; MLS001076071; MLS001424164; SPECTRUM2300206; SPBio_001953; BPBio1_000016; GTPL2409; orb1225191; orb1310912; DIAZOXIDE [ORANGE BOOK]; DIAZOXIDE [EP MONOGRAPH]; SCHEMBL29384603; SCHEMBL31112206; BDBM86248; HY-B1140R; KBio2_000027; KBio2_002595; KBio2_005163; KBio3_000053; KBio3_000054; KBio3_001510; DIAZOXIDE [USP MONOGRAPH]; DIAZOXIDUM [WHO-IP LATIN]; 7-chloro-3-methyl-4h-1|E6,2,4-benzothiadiazine 1,1-dioxide; Bio1_000036; Bio1_000525; Bio1_001014; Bio2_000027; Bio2_000507; GLXC-06094; HMS1361B09; HMS1568A16; HMS1791B09; HMS1922L22; HMS1989B09; HMS2051P20; HMS2089L04; HMS2093N12; HMS2095A16; HMS2234B23; HMS3261A10; HMS3267I11; HMS3371L13; HMS3393P20; HMS3402B09; HMS3411L18; HMS3675L18; HMS3712A16; HMS3885H12; HMS5083M04; Pharmakon1600-02300206; 2H-1,2, 4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide; 7-Chloro-3-methyl-1lambda~4~,2,4-benzothiadiazin-1-ol 1-oxide; HY-B1140; MSK10638; NSC_3019; Tox21_110132; Tox21_500404; BDBM50237612; EBC-13327; HB0244; KC-115; NSC759574; s4630; AKOS015896340; AKOS024458715; Tox21_110132_1; CCG-101062; CCG-204497; CS-4745; DB01119; Diazoxide 100 |Ig/mL in Acetonitrile; FD21519; KS-1444; LP00404; NC00312; NSC-759574; SDCCGSBI-0050390.P002; IDI1_033777; Diazoxide 100 microg/mL in Acetonitrile; NCGC00015380-01; NCGC00015380-02; NCGC00015380-03; NCGC00015380-04; NCGC00015380-05; NCGC00015380-06; NCGC00015380-07; NCGC00015380-08; NCGC00015380-10; NCGC00015380-11; NCGC00015380-12; NCGC00015380-13; NCGC00015380-15; NCGC00015380-20; NCGC00022882-03; NCGC00024907-01; NCGC00024907-02; NCGC00024907-03; NCGC00024907-04; NCGC00024907-05; NCGC00024907-06; NCGC00024907-07; NCGC00024907-08; NCGC00261089-01; CAS_364-98-7; SY066792; DB-048966; D5402; EU-0100404; NS00008680; VU0239714-6; C06949; D00294; EN300-122611; F12855; F047209; Q420009; SR-01000075314-1; SR-01000075314-3; SR-01000075314-4; SR-01000075314-6; 3-methyl-7-chloro-1,2,4-benzothiadiazine1,1-dioxide; BRD-K73109821-001-05-2; BRD-K73109821-001-10-2; BRD-K73109821-001-19-3; BRD-K73109821-001-20-1; Z1269122570; Diazoxide, European Pharmacopoeia (EP) Reference Standard; 4H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide; 7-chloro-3-methyl-2H-1lambda6,2,4-benzothiadiazine-1,1-dione; Diazoxide, United States Pharmacopeia (USP) Reference Standard; 7-Chloro-3-methyl-1lambda~6~,2,4-benzothiadiazine-1,1(2H)-dione; 7-chloro-3-methyl-2H-1$l^{6},2,4-benzothiadiazine 1,1-dioxide동의어
